24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Blindness
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
23:35
Anthropic prices IPO at $83, valuing Claude maker at $1.5 trillion
23:24
Palo Alto Networks jumps after earnings beat and $4.5 billion AI acquisition
22:06
"In the AI era, cyber needs to be thought of in terms of tasks rather than products or tools"
21:59
"Today it's not enough to block an agent, you need to explain to it why you did so"
More stories
Buzz
Most popular
Daily
Weekly
1
After years in development, Elbit's airborne laser weapons move closer to production
2
The Israeli business Nvidia bought for $6.9 billion now generates $21 billion a quarter
3
Intel employees report new IT layoffs as restructuring continues
4
Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.
5
Amazon set to seal Decart deal worth up to $7.5 billion within days
More news
Blindness
1 stories about Blindness
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma